Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 5310135017 | Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 5310136016 | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Is a | Product containing only emtricitabine and rilpivirine and tenofovir (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some | ||
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Has active ingredient | Emtricitabine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Has active ingredient | Tenofovir (substance) | true | Inferred relationship | Some | 2 | |
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Has active ingredient | Rilpivirine | true | Inferred relationship | Some | 3 | |
| Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Is a | Emtricitabine- and rilpivirine- and tenofovir-containing product in oral dose form | true | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet | Is a | True | Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Is a | True | Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | Inferred relationship | Some | 
This concept is not in any reference sets